141 related articles for article (PubMed ID: 35220546)
1. Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions.
Kaur H; Kala S; Sood A; Mridha AR; Kakkar A; Yadav R; Mishra S; Mishra D
Head Neck Pathol; 2022 Sep; 16(3):728-737. PubMed ID: 35220546
[TBL] [Abstract][Full Text] [Related]
2. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions.
Tabareau-Delalande F; Collin C; Gomez-Brouchet A; Bouvier C; Decouvelaere AV; de Muret A; Pagès JC; de Pinieux G
Mod Pathol; 2015 Jan; 28(1):48-56. PubMed ID: 24925056
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of radiological and clinicopathological features of craniofacial fibro-osseous lesions].
Yang XD; Xu G; Song LH; Zhu H; Liu X; Li FH; Peng SK; Ma ZY; Zhou H
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):122-128. PubMed ID: 32074723
[No Abstract] [Full Text] [Related]
5. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
[TBL] [Abstract][Full Text] [Related]
6. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
[TBL] [Abstract][Full Text] [Related]
7. SATB2 and MDM2 Immunoexpression and Diagnostic Role in Primary Osteosarcomas of the Jaw.
Owosho AA; Ladeji AM; Adesina OM; Adebiyi KE; Olajide MA; Okunade T; Palmer J; Kehinde T; Vos JA; Cole G; Summersgill KF
Dent J (Basel); 2021 Dec; 10(1):. PubMed ID: 35049602
[TBL] [Abstract][Full Text] [Related]
8. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
[TBL] [Abstract][Full Text] [Related]
9. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
10. MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones.
Bahceci DH; Jordan RCK; Horvai AE
Head Neck Pathol; 2022 Dec; 16(4):991-997. PubMed ID: 35546651
[TBL] [Abstract][Full Text] [Related]
11. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract][Full Text] [Related]
13. The importance of clinical and radiological findings for the definitive histopathologic diagnosis of benign fibro-osseous lesions of the jaws: Study of 276 cases.
Soluk-Tekkesin M; Sinanoglu A; Selvi F; Cakir Karabas H; Aksakalli N
J Stomatol Oral Maxillofac Surg; 2022 Jun; 123(3):364-371. PubMed ID: 33878496
[TBL] [Abstract][Full Text] [Related]
14. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
15. Benign Fibro-Osseous Lesions of the Head and Neck.
Nelson BL; Phillips BJ
Head Neck Pathol; 2019 Sep; 13(3):466-475. PubMed ID: 30887390
[TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
18. Locally aggressive fibrous dysplasia.
Kashima TG; Gamage NM; Ye H; Amary MF; Flanagan AM; Ostlere SJ; Athanasou NA
Virchows Arch; 2013 Jul; 463(1):79-84. PubMed ID: 23760783
[TBL] [Abstract][Full Text] [Related]
19. Soft Tissue Special Issue: Gnathic Fibro-Osseous Lesions and Osteosarcoma.
Hameed M; Horvai AE; Jordan RCK
Head Neck Pathol; 2020 Mar; 14(1):70-82. PubMed ID: 31950477
[TBL] [Abstract][Full Text] [Related]
20. Benign and Malignant Proliferative Fibro-osseous and Osseous Lesions of the Oral Cavity of Dogs.
Soltero-Rivera M; Engiles JB; Reiter AM; Reetz J; Lewis JR; Sánchez MD
Vet Pathol; 2015 Sep; 52(5):894-902. PubMed ID: 25957357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
